Scientist plan to turn cells from endangered animals into sperm and eggs to save them from extinction. Could this money be better spent saving many more species from becoming endangered in the first place?

It is a conundrum. Costly regulatory hurdles to get a GM food to market mean only big multinationals such as Monsanto can afford to take research to a commercial stage.

Cisgenics is being held up as a plant breeding technology distinct from the techniques that produce GM food. I think not.

COSMOS magazine and the Australian government have created a splendid new education resource for teachers – and its free.

Andrew Maynard’s analysis of each of Friends of the Earth’s claims about nanoparticles in sunscreens

The question is which one and how much. There are conflicting reports from various news agencies.

There’s an interesting symposium on the social implications of emerging technologies starting today, and yes cyborg rights is one keynote topic.

A hard call when you are not living in a dying man’s shoes, but this insight into the purpose of clinical trials is well, clinical.

American J of Bioethics devotes its May issue to the topic of stem cell tourism with insight into industry drivers and the power if hope, but if hope trumps everything why bother with informed dialogue?

Not likely. This is another miracle stem cell treatment doing the rounds.